New frontiers in type I diabetes treatment: the impact of mesenchymal stromal cells on long-term complications
Type 1 diabetes (T1D) is not only a disorder of insulin production from beta cell destruction, but also a progressive condition that brings about life-threatening complications such as diabetic nephropathy, impaired wound recovery, and cardiovascular disease. Mesenchymal stromal cell (MSC) use has r...
Saved in:
| Main Authors: | Deeptha Bejugam, Sarah Bu, Athena N. Nguyen, Mariam Yaltaghian, Kinga K Smolen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Clinical Diabetes and Healthcare |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcdhc.2025.1586061/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Activation of angiopoietin-1 signaling with engineering mesenchymal stem cells promoted efficient angiogenesis in diabetic wound healing
by: Qiong Deng, et al.
Published: (2025-02-01) -
The Effect of Conditioned Medium from Angiopoietin-1 Gene-Modified Mesenchymal Stem Cells on Wound Healing in a Diabetic Mouse Model
by: Qiong Deng, et al.
Published: (2024-12-01) -
One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study
by: Jing Lu, et al.
Published: (2021-06-01) -
Hypoxia-Conditioned Mesenchymal Stem Cells (HC-MSC)-Derived Secretome Gel Induce IL-10 to Improve Diabetic Foot Ulcers via Reduced NF-κB p65 Gene Expression: A Randomized Controlled Trial
by: Nur Anna Chalimah Sadyah, et al.
Published: (2025-03-01) -
The Effect of Stem Cell Secretome on the Improvement of Diabetic Wound Recovery: A Systematic Review and Meta-Analysis of In Vivo Studies
by: Cecep Suhandi, MSc, et al.
Published: (2025-01-01)